Unresolved disorder model. using A ATOM 338 OG1ATHR 45 28.206 4.344 13.936 0.50 21.30 O Unresolved disorder model. using A ATOM 339 OG1BTHR 45 29.454 5.922 12.984 0.50 21.04 O Unresolved disorder model. using A ATOM 340 CG2ATHR 45 29.515 5.979 12.771 0.50 22.23 C Unresolved disorder model. using A ATOM 341 CG2BTHR 45 27.891 4.864 11.507 0.50 17.20 C Unresolved disorder model. using A ATOM 612 N AVAL 81 15.444 42.321 11.944 0.70 17.81 N Unresolved disorder model. using A ATOM 613 N BVAL 81 15.429 42.314 11.933 0.30 17.59 N Unresolved disorder model. using A ATOM 614 CA AVAL 81 14.475 43.060 11.144 0.70 19.44 C Unresolved disorder model. using A ATOM 615 CA BVAL 81 14.466 43.042 11.105 0.30 18.59 C Unresolved disorder model. using A ATOM 616 C AVAL 81 15.090 44.450 11.011 0.70 19.42 C Unresolved disorder model. using A ATOM 617 C BVAL 81 15.036 44.456 10.997 0.30 19.41 C Unresolved disorder model. using A ATOM 618 O AVAL 81 15.283 45.140 12.008 0.70 18.49 O Unresolved disorder model. using A ATOM 619 O BVAL 81 15.181 45.156 12.001 0.30 19.02 O Unresolved disorder model. using A ATOM 620 CB AVAL 81 13.098 43.147 11.845 0.70 20.46 C Unresolved disorder model. using A ATOM 621 CB BVAL 81 13.029 43.007 11.689 0.30 18.57 C Unresolved disorder model. using A ATOM 622 CG1AVAL 81 12.175 44.066 11.063 0.70 22.52 C Unresolved disorder model. using A ATOM 623 CG1BVAL 81 12.989 43.550 13.106 0.30 17.25 C Unresolved disorder model. using A ATOM 624 CG2AVAL 81 12.482 41.757 11.940 0.70 21.24 C Unresolved disorder model. using A ATOM 625 CG2BVAL 81 12.046 43.734 10.779 0.30 19.14 C Unresolved disorder model. using A ATOM 717 CG1AILE 95 16.832 26.809 2.391 0.50 18.75 C Unresolved disorder model. using A ATOM 718 CG1BILE 95 16.009 24.514 3.016 0.50 20.47 C Unresolved disorder model. using A ATOM 719 CG2AILE 95 16.024 24.509 3.002 0.50 18.45 C Unresolved disorder model. using A ATOM 720 CG2BILE 95 18.368 24.977 2.285 0.50 20.22 C Unresolved disorder model. using A ATOM 721 CD1AILE 95 16.716 26.684 0.885 0.50 20.31 C Unresolved disorder model. using A ATOM 722 CD1BILE 95 15.123 24.722 1.804 0.50 22.96 C Unresolved disorder model. using A ATOM 874 CG ALEU 113 11.401 39.067 8.206 0.50 20.45 C Unresolved disorder model. using A ATOM 875 CG BLEU 113 12.749 37.632 8.773 0.50 20.61 C Unresolved disorder model. using A ATOM 876 CD1ALEU 113 10.377 37.945 8.059 0.50 19.54 C Unresolved disorder model. using A ATOM 877 CD1BLEU 113 13.007 38.369 10.084 0.50 20.20 C Unresolved disorder model. using A ATOM 878 CD2ALEU 113 11.602 39.422 9.669 0.50 21.14 C Unresolved disorder model. using A ATOM 879 CD2BLEU 113 11.413 36.911 8.816 0.50 19.91 C Unresolved disorder model. using A ATOM 1015 OG ASER 131 24.387 37.727 7.860 0.50 17.09 O Unresolved disorder model. using A ATOM 1016 OG BSER 131 24.356 37.652 5.556 0.50 16.59 O Unresolved disorder model. using A ATOM 2310 CG AGLN 297 8.727 15.791 9.510 0.50 19.56 C Unresolved disorder model. using A ATOM 2311 CG BGLN 297 8.874 15.748 9.388 0.50 20.65 C Unresolved disorder model. using A ATOM 2312 CD AGLN 297 8.789 14.321 9.880 0.50 20.09 C Unresolved disorder model. using A ATOM 2313 CD BGLN 297 10.324 15.873 8.959 0.50 22.23 C Unresolved disorder model. using A ATOM 2314 OE1AGLN 297 7.762 13.650 9.988 0.50 22.15 O Unresolved disorder model. using A ATOM 2315 OE1BGLN 297 10.626 16.000 7.772 0.50 23.96 O Unresolved disorder model. using A ATOM 2316 NE2AGLN 297 10.001 13.814 10.084 0.50 22.08 N Unresolved disorder model. using A ATOM 2317 NE2BGLN 297 11.232 15.829 9.929 0.50 24.23 N 1